MAMasao Akagi

Masao Akagi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masao Akagi has a total of 182 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Changes in coronal tibiofemoral subluxation before and after medial unicompartmental knee arthroplasty: an observation for ten years

    by Kotaro Yamagishi, Masao Akagi, Shigeki Asada, Teruaki Hashimoto, Akihiro Moritake, Koichi Nakagawa, Shigeshi Mori, Koji Goto

    Introduction Residual coronal tibiofemoral subluxation (CTFS) can cause peripheral contact between the implant components after medial unicompartmental knee arthroplasty (UKA), resulting in premature failure. The aim of this study was to investigate the changes in CTFS before and after surgery. Methods Fifty-nine knees of 51 patients who underwent fixed-bearing medial UKA were retrospectively analyzed. CTFS was measured using anteroposterior knee radiographs in the standing position and under valgus stress before surgery and at two weeks and one, five, and 10 years after surgery. The preoperative and postoperative alignment of the knee and tibial component inclination angle (TCIA) were also evaluated. Results Mean preoperative CTFS decreased significantly from 4.6 ± 1.5 mm in the standing position to 3.3 ± 1.1 mm under valgus stress and to 3.5 ± 1.4 mm in the standing position immediately after surgery. No changes in mean CTFS were observed during the 10-year follow-up period. The CTFS at 2 weeks after surgery was strongly correlated positively with the CTFS at the 10-year follow-up and the preoperative CTFS under valgus stress. The postoperative medial proximal tibial angle (MPTA) was strongly correlated negatively with the two-week postoperative CTFS, while TCIA was significantly correlated positively with that. Conclusions Residual CTFS after medial UKA did not change during the mid-term follow-up period, which was predictable to some extent based on the observations noted using the preoperative valgus stress radiographs. Close attention should be paid to patients with severe uncorrectable preoperative CTFS and small MPTA values when considering the indications for medial UKA. Level of evidence IV.


  • Open Access

    Fabrication of Artificial Nerve Conduits Used in a Long Nerve Gap: Current Reviews and Future Studies

    by Ryosuke Kakinoki, Yukiko Hara, Koichi Yoshimoto, Yukitoshi Kaizawa, Kazuhiko Hashimoto, Hiroki Tanaka, Takaya Kobayashi, Kazuhiro Ohtani, Takashi Noguchi, Ryosuke Ikeguchi, et al.

    There are many commercially available artificial nerve conduits, used mostly to repair short gaps in sensory nerves. The stages of nerve regeneration in a nerve conduit are fibrin matrix formation between the nerve stumps joined to the conduit, capillary extension and Schwann cell migration from both nerve stumps, and, finally, axon extension from the proximal nerve stump. Artificial nerves connecting transected nerve stumps with a long interstump gap should be biodegradable, soft and pliable; have the ability to maintain an intrachamber fibrin matrix structure that allows capillary invasion of the tubular lumen, inhibition of scar tissue invasion and leakage of intratubular neurochemical factors from the chamber; and be able to accommodate cells that produce neurochemical factors that promote nerve regeneration. Here, we describe current progress in the development of artificial nerve conduits and the future studies needed to create nerve conduits, the nerve regeneration of which is compatible with that of an autologous nerve graft transplanted over a long nerve gap.


  • Open Access

    How proximal femur fracture patients aged 65 and older fare in survival and cause of death 5+ years after surgery: A long-term follow-up

    by Kazuhiko Hashimoto, Yu Shinyashiki, Kazuhiro Ohtani, Ryosuke Kakinoki, Masao Akagi

    Although the incidence of proximal femur fractures (PFFs) is increasing, few detailed reports on associated long-term outcomes and causes of death exist. We aimed to evaluate long-term outcomes and causes of death ≥5 years after surgical treatment of PFFs. This retrospective study included 123 patients (18 males, 105 females) with PFFs treated at our hospital between January 2014 and December 2016. Cases (median age: 90 [range, 65–106] years) comprised 38 femoral neck fractures (FNFs) and 85 intertrochanteric fractures (IFs). Surgical procedures included bipolar head arthroplasty (n = 35), screw fixation (n = 3), and internal fixation with nails (n = 85). The mean post-surgical follow-up time was 58.9 (range, 1–106) months. Surveyed items included survival (1 vs 5 years; sex; age, >90 vs P = .89) at 1 and 5 years, respectively. OS rates for the P < .01) at 1 and 5 years, respectively. The 1- and 5-year OS (IF/FNF) rates were 85.7%/88.8% and 60%/81.5%, respectively; patients with IFs had significantly lower OS than those with FNFs at both timepoints (P = .015). There was a marked difference in the operative time between died (43.5 ± 24.0: mean ± S.D.) and survived (60 ± 24.4: mean ± S.D.) patients. The main causes of death were senility (n = 10), aspiration pneumonia (n = 9), bronchopneumonia (n = 6), worsening heart failure (n = 5), acute myocardial infarction (n = 4), and abdominal aortic aneurysm (n = 4). Overall, 30.4% of the cases were related to comorbidities and related causes (e.g., hypertension-related ruptured large abdominal aneurysm). Managing comorbidities may improve long-term postoperative outcomes of PFF treatment.


  • Open Access

    Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors

    by Kazuhiko Hashimoto, Shunji Nishimura, Yu Shinyashiki, Tomohiko Ito, Ryosuke Kakinoki, Masao Akagi

    The details of immune molecules' expression in desmoid tumors (DTs) remain unclear. This study aimed to determine the expression status of the programmed death-1/programmed death ligand 1 (PD1/PD-L1) immune checkpoint mechanism in DTs. The study included patients with DTs (n=9) treated at our institution between April 2006 and December 2012. Immunostaining for CD4, CD8, PD-1, PD-L1, interleukin-2 (IL-2), and interferon-gamma (IFN-γ) was performed on pathological specimens harvested during the biopsy. The positivity rate of each immune component was calculated as the number of positive cells/total cells. The positivity rate was quantified and correlations between the positivity rates of each immune molecule were also investigated. Immune molecules other than PD-1 were stained in tumor cells and intra-tumor infiltrating lymphocytes. The mean ± SD expression rates of β-catenin, CD4, CD8, PD-1, PD-L1, IL-2, and IFN-ɤ were 43.9±18.9, 14.6±6.80, 0.75±4.70, 0±0, 5.1±6.73, 8.75±6.38, and 7.03±12.1, respectively. The correlation between β-catenin and CD4 was positively moderate (r=0.49); β-catenin and PD-L1, positively weak (r=0.25); CD4 and PD-L1, positively medium (r=0.36); CD8 and IL-2, positively medium (r=0.38); CD8 and IFN-ɤ, positively weak (r=0.28); and IL-2 and IFN-ɤ, positively medium (r=0.36). Our findings suggest that PD-L1-centered immune checkpoint mechanisms may be involved in the tumor microenvironment of DTs.


  • Open Access

    Early subchondral bone loss plays an important role in initiation and progression of osteoarthritis in the mouse DMM model

    by Teruaki Hashimoto, Masao Akagi, Kazuhiko Hashimoto, Takafumi Morishita, Ichiro Tsukamoto, Tomohiko Ito

    Introduction: Recently, uncoupled bone remodeling in the subchondral bone (SB) has been considered an important process to promote knee osteoarthritis (KOA). However, it is unclear how SB metabolism in the early stage of KOA affects the initiation and progression of the disease. This study aimed to investigate the relationship between the early changes in SB and the disease process, using wild-type (WT) mice and Tsukuba hypertensive mice (THM) with high-turnover bone metabolism. Methods Destabilization of the medial meniscus (DMM) or sham surgery was performed on the left knee of male 40-week-old THM and WT mice (n = 7 in each group). Bone volume/tissue volume (BV/TV), bone mineral density (BMD), and mean height (Hm, µm) in the medial tibial SB were longitudinally measured in vivo using micro-computed tomography (µCT) at 0, 1, 2, 4, 8, and 12 weeks postoperatively. Tibial cartilage degeneration was evaluated histologically using the OARSI score at 0, 1, 2, 4, 8, and 12 weeks postoperatively (n = 7 in each group). Results Significant decreases in BV/TV in both WT + DMM and THM + DMM groups were evident at 1 and 4 weeks postoperatively, respectively. Notably, significant decreases in the BMD (at 2 and 8 weeks postoperatively) and Hm (at 4 and 12 weeks postoperatively), and significant increases in the Osteoarthritis Research Society International (OARSI) score (at 2 and 8 weeks postoperatively) in the THM + DMM and WT + DMM groups were observed, respectively. A strong correlation was noted between the Hm and the BMD. These time-dependent changes in the BV/TV, BMD, Hm in the SB, and OARSI score were significantly enhanced in the THM + DMM group compared to the WT + DMM group. Conclusions These results indicate that SB loss at the early stage and the subsequent uncoupled bone remodeling, which can be enhanced by high-turnover osteoporosis, play an important role in the initiation and progression of KOA in the mouse DMM model. SB loss in the early stage could be a key target for preventing the initiation and progression of the disease.

  • Open Access

    Novel reconstruction method by mega-prosthesis wrapped with vancomycin-containing cement after resection of malignancies

    by Kazuhiko Hashimoto, Shunji Nishimura, Yu Shinyashiki, Tomohiko Ito, Ryosuke Kakinoki, Masao Akagi

    To introduce wrapping vancomycin-containing cement around a mega-prosthesis (MP) as a novel method to prevent prosthetic joint infection after reconstruction surgery for malignant bone and soft tissue tumors. Five patients with malignant bone and soft tissue tumors treated at our hospital from April 2009 to December 2019 were included. The average age was 71.4 years. Four males and one female were included. Three patients had a bone tumor, and two had a soft tissue tumor. Three right thighs and two left femurs were affected. These tumors were identified histologically as undifferentiated pleomorphic sarcoma, spindle cell sarcoma, diffuse large cell B-cell lymphoma, metastasis of renal cancer, and metastasis of lung cancer. All patients underwent tumor resection and reconstruction with a MP. In all cases, vancomycin-containing cement (2 g/40 g) was wrapped around the implant at the extension. The average follow-up period was 30.4 months. We surveyed whether infection occurred after surgical treatment. We also investigated the Musculoskeletal Tumor Society score and clinical outcome. We observed no postoperative infection. One case of local recurrence was observed, and a hip dissection was performed. The Musculoskeletal Tumor Society score was 79.26 ± 1.26 (mean ± standard deviation) (range: 76‐80.3). Three patients remained disease-free, one survived but with disease, and one died of disease. Wrapping vancomycin-containing cement around the MP may be a useful method of preventing postoperative joint infections.


  • Open Access

    Referencing the Tibial Plateau With a Probe Improves the Accuracy of the Posterior Slope in Medial Unicompartmental Knee Arthroplasty

    by Masao Akagi, Akihiro Moritake, Kotaro Yamagishi, Shigeshi Mori, Koichi Nakagawa, Hisafumi Aya


  • Open Access

    Characterizing inflammatory markers in highly aggressive soft tissue sarcomas

    by Kazuhiko Hashimoto, Shunji Nishimura, Yu Shinyashiki, Tomohiko Ito, Masao Akagi

    The prognosis for soft tissue sarcomas (STSs) is poor, especially for highly aggressive STSs, and the details of prognostic factors are unknown. This study aimed to investigate the prognostic factors for STSs in hematologic inflammatory markers. We included 22 patients with STSs treated at our institution. The STSs were histologically classified as follows: undifferentiated pleomorphic sarcoma, 7 cases; myxofibrosarcoma, 6 cases; and malignant peripheral nerve sheath tumor, 2 cases. The average patient age was 72.06 years. The numbers of patients who underwent each procedure were as follows: wide resection, 7; wide resection and flap, 2; marginal resection, 2; wide resection and radiation, 1; additional wide resection with flap, 1; wide resection and skin graft, 1; and radiotherapy only, 1. The median follow-up period was 26 months (3–92 months). The outcomes were as follows: continuous disease free, 6 cases; no evidence of disease, 6 cases; alive with disease, 1 case; and died of disease, 2 cases. Pretreatment blood examinations for C-reactive protein (CRP) and albumin levels; neutrophil, lymphocyte, and white blood cell (WBC) counts; and neutrophil/lymphocyte (N/L) ratio were investigated and correlated with tumor size, tissue grade, and maximum standardized uptake value (SUVmax). CRP level and neutrophil and WBC counts were positively correlated with tissue grade and SUVmax. N/L ratio was positively correlated with tumor size and SUVmax. CRP level, WBC and neutrophil counts, and N/L ratio may be poor prognostic factors for highly aggressive STSs.


  • Open Access

    Comprehensive treatment outcomes of giant cell tumor of the spine: A retrospective study

    by Kazuhiko Hashimoto, Shunji Nishimura, Hiroshi Miyamoto, Kensuke Toriumi, Terumasa Ikeda, Masao Akagi

    There is no consensus on a treatment strategy for spinal giant cell tumor of bone (GCTB) because of the difficulty in their treatment. Treatment options often include the use of the controversial denosumab, an antibody therapy aimed at tumor shrinkage, different curettage techniques, resection, or a combination of these therapies. The current study aimed to identify treatment methods associated with favorable outcomes in patients with spinal GCTB. We retrospectively reviewed 5 patients with spinal GCTB, including patients with tumors of the sacrum, treated at our hospital between September 2011 and November 2020. Two men and 3 women were included in the study. The median follow-up period was 74 months (range: 14–108 months). We surveyed the tumor site, treatment method, denosumab use, and outcomes. The median age was 17 years (range: 17–42 years). There were 2 cases of sacral GCTB and 1 case each of lumbar, cervical, and thoracic vertebral GCTB. The comorbidities observed included hepatitis, malignant lymphoma, atopic dermatitis, and asthma. The treatment method included zoledronic acid after embolization and denosumab, denosumab only, curettage and posterior fusion, and curettage resection after embolization and anterior and posterior fusion. Denosumab was used in all cases. Three patients were continuously disease-free, 1 patient with no evidence of disease, and 1 patient alive with disease. Aggressive treatment, especially surgical treatment, may lead to good results in spinal GCTB.


  • Open Access

    PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report

    by Kazuhiko Hashimoto, Shunji Nishimura, Yu Shinyashiki, Tomohiko Ito, Hiroki Tanaka, Kazuhiro Ohtani, Ryosuke Kakinoki, Masao Akagi

    Rationale: The genomic alteration of cutaneous angiosarcoma (cAS) is complex. Treatment efficacy of immunotherapy for cAS remains controversial and prognosis remains poor. Herein, we report a case of cAS with programmed cell death 1, programmed cell death ligand-1, New York esophageal squamous cell carcinoma-1, and melanoma-associated antigen 4. Patient concerns: A 69-year-old man presented with a chief complaint of left thumb pain, with a soft tissue mass in the palmar side of the thumb. He had no past medical history. Three months prior, the man experienced the pain while scuba diving. He visited a nearby clinic, and magnetic resonance imaging revealed a soft tissue tumor on the palmar side of the thumb. He was referred to our hospital and a marginal excisional biopsy was performed. Diagnosis: Pathological findings revealed an angiosarcoma with high-flow serpentine vessels. Interventions: An excision was performed from the base of the thumb to achieve a wide margin. Outcomes: One year after the treatment, the patient has not experienced recurrence, metastasis, or complications. Lessons: Histopathology of the excised specimen was positive for programmed cell death 1, programmed cell death ligand-1, New York esophageal squamous cell carcinoma-1, and melanoma-associated antigen 4; their expression may be a therapeutic target for cAS. Combining immunotherapy with surgical treatment may be effective for cAS.